Literature DB >> 19222088

A shield against a monster: Hepatitis C in hemodialysis patients.

Seyed-Moayed Alavian.   

Abstract

Hepatitis C virus (HCV) infection is highly prevalent among patients on hemodialysis (HD). The prevalence of HCV infection in HD patients varies markedly from country to country. Some factors are especially related to these high prevalence rates, such as blood transfusions and length of dialysis time. Nosocomial routes of transmission including the use of contaminated equipment and patient-to-patient exposure is considered more important. Several prophylactic measures have been suggested to avoid infection by HCV in the HD environment.

Entities:  

Mesh：

Year:  2009        PMID： 19222088      PMCID： PMC2653433          DOI： 10.3748/wjg.15.641

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN： 1007-9327            Impact factor:   5.742


  101 in total

1.  Results of a national epidemiological investigation of HCV infection in dialysis patients.

Authors:  M Lombardi; T Cerrai; S Geatti; S Negroni; L Pertusini; M Pegoraro; G Di Lullo
Journal:  EDTNA ERCA J       Date:  1999 Jul-Sep

2.  Occasional infection of hepatitis C virus occurring in haemodialysis units identified by serial monitoring of the virus infection.

Authors:  Y Iwasaki; M Esumi; N Hosokawa; M Yanai; K Kawano
Journal:  J Hosp Infect       Date:  2000-05       Impact factor: 3.926

3.  Systematic monitor disinfection is effective in limiting HCV spread in hemodialysis.

Authors:  F Aucella; M Vigilante; G L Valente; C Stallone
Journal:  Blood Purif       Date:  2000       Impact factor: 2.614

4.  Impact of hepatitis B and C virus on kidney transplantation outcome.

Authors:  P Mathurin; C Mouquet; T Poynard; C Sylla; H Benalia; C Fretz; V Thibault; J F Cadranel; B Bernard; P Opolon; P Coriat; M O Bitker
Journal:  Hepatology       Date:  1999-01       Impact factor: 17.425

5.  Hepatitis virus infection in haemodialysis patients from Moldavia.

Authors:  A Covic; L Iancu; C Apetrei; D Scripcaru; C Volovat; I Mititiuc; M Covic
Journal:  Nephrol Dial Transplant       Date:  1999-01       Impact factor: 5.992

6.  Prevention of nosocomial transmission of hepatitis C infection in a hemodialysis unit. A prospective study.

Authors:  V Djordjević; K Stojanović; M Stojanović; V Stefanović
Journal:  Int J Artif Organs       Date:  2000-03       Impact factor: 1.595

7.  Prevalence of hepatitis C virus infection at three hemodialysis units in the western region of Puerto Rico.

Authors:  P J López-Navedo; R Lebrón-Rivera; J González-Trápaga; J Weber-Acevedo; E Lefevre-Ramos; E Flores-de Hostos; F Jaume-Anselmi; J Ramírez-Rivera
Journal:  Bol Asoc Med P R       Date:  1999 Jul-Dec

8.  Infections with hepatitis B and C viruses in patients on maintenance dialysis in Romania and in former communist countries: yellow spots on a blank map?

Authors:  D S Vladutiu; A Cosa; A Neamtu; D State; M Braila; M Gherman; I M Patiu; I Dulau-Florea
Journal:  J Viral Hepat       Date:  2000-07       Impact factor: 3.728

9.  Risk of death among chronic dialysis patients infected with hepatitis C virus.

Authors:  C O Stehman-Breen; S Emerson; D Gretch; R J Johnson
Journal:  Am J Kidney Dis       Date:  1998-10       Impact factor: 8.860

10.  Molecular evidence of nosocomial transmission of hepatitis C virus in a haemodialysis unit.

Authors:  Y H Abacioglu; F Bacaksiz; I H Bahar; P Simmonds
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2000-03       Impact factor: 3.267
View more
  10 in total

Review 1.  Prevalence of hepatitis C virus infection among hemodialysis patients in the Middle-East: A systematic review and meta-analysis.

Authors:  Soheil Ashkani-Esfahani; Seyed Moayed Alavian; Mohammad Salehi-Marzijarani
Journal:  World J Gastroenterol       Date:  2017-01-07       Impact factor: 5.742

Review 2.  Renal dysfunction in chronic liver disease.

Authors:  Andy Slack; Andrew Yeoman; Julia Wendon
Journal:  Crit Care       Date:  2010-03-09       Impact factor: 9.097

Review 3.  Epidemiology of hepatitis C in Croatia in the European context.

Authors:  Tatjana Vilibic-Cavlek; Jasmina Kucinar; Bernard Kaic; Maja Vilibic; Nenad Pandak; Ljubo Barbic; Vladimir Stevanovic; Jasmina Vranes
Journal:  World J Gastroenterol       Date:  2015-08-28       Impact factor: 5.742

Review 4.  Management of hepatitis C virus infection in hemodialysis patients.

Authors:  Yue-Cheng Yu; Yue Wang; Chang-Lun He; Mao-Rong Wang; Yu-Ming Wang
Journal:  World J Hepatol       Date:  2014-06-27

5.  Management of the kidney transplant patient with chronic hepatitis C infection.

Authors:  Ignatius Y S Tang; Natasha Walzer; Nidhi Aggarwal; Ivo Tzvetanov; Scott Cotler; Enrico Benedetti
Journal:  Int J Nephrol       Date:  2011-04-26

6.  Rising burden of Hepatitis C Virus in hemodialysis patients.

Authors:  Sanaullah Khan; Sobia Attaullah; Ijaz Ali; Sultan Ayaz; Shahid Niaz Khan; Sami Siraj; Jabbar Khan
Journal:  Virol J       Date:  2011-09-13       Impact factor: 4.099

7.  An unbelievable fact on "dialysis centers without hepatitis C infection".

Authors:  Seyed Moayed Alavian
Journal:  Nephrourol Mon       Date:  2014-03-01

Review 8.  Prevalence of hepatitis C infection in Iranian hemodialysis patients: An updated systematic review and meta-analysis.

Authors:  Nahid Ramezan Ghorbani; Shirin Djalalinia; Mitra Modirian; Zahra Esmaeili Abdar; Morteza Mansourian; Armita Mahdavi Gorabi; Hamid Asayesh; Hossein Ansari; Mehrdad Kazemzadeh Atoofi; Ramin Tajbakhsh; Mehdi Noroozi; Saeid Safiri; Mostafa Qorbani
Journal:  J Res Med Sci       Date:  2017-11-28       Impact factor: 1.852

9.  The prevalence of hepatitis C virus in hemodialysis patients in Pakistan: A systematic review and meta-analysis.

Authors:  Sohail Akhtar; Jamal Abdul Nasir; Muhammad Usman; Aqsa Sarwar; Rizwana Majeed; Baki Billah
Journal:  PLoS One       Date:  2020-05-14       Impact factor: 3.240

10.  Diagnostic Performance of an Immunoassay for Simultaneous Detection of Hcv Core Antigen and Antibodies among Haemodialysis Patients.

Authors:  Wafaa M El-Emshaty; Douaa Raafat; Doaa M Elghannam; Niveen Saudy; Ehab E Eltoraby; Abd Elhameed A Metwalli
Journal:  Braz J Microbiol       Date:  2011-01       Impact factor: 2.476
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.